Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Glioma × 90 days × Clear all

Phase

Status

Recruiting 69 Active not recruiting 39 Not yet recruiting 23 Completed 19 Terminated 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Triple Negative Breast Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Brain Neoplasms 4 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Glioblastoma 3 Depression 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Renal Insufficiency, Chronic 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm, Residual 2 Lymphoma, Follicular 2 Lymphoma 2 Fatigue 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Carcinoma In Situ 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1

Interventions

fluoromisonidazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04309552 2026-01-27

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Weill Medical College of Cornell University

Phase 1 Suspended

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡